Course NURS-6521N Advanced Pharmacology Test Week 6 -Quiz Started 7/7/19 Submitted 7/7/19 Status Completed Attempt Score 30 out of 30 points Time Elapsed 47 minutes out of 1 hour and 15 minutes Instructions Please answer each question below and click Submit when you have completed the Quiz. Results Displayed Feedback Question 1 1 out of 1 points A nurse is caring for a 61-year-old man who has had a severe attack of gout while in the hospital for food poisoning. The nurse administers colchicine intravenously in order to Response Feedback: The patient is given colchicine intravenously to avoid aggravating his gastrointestinal tract. Giving the drug intravenously may ensure quick distribution of the drug, but considering the patient's food poisoning, the main objective would be to avoid aggravating the gastrointestinal tract and symptoms that the patient already has. Giving the drug intravenously does not prevent infection, bleeding, or depressed bone marrow function. Question 2 1 out of 1 points A 32-year-old female patient is taking tizanidine (Zanaflex) for spasticity related to her multiple sclerosis. The nurse will inform the patient and her husband that the adverse effect that poses the greatest safety risk to the patient is Response Feedback: Tizanidine (Zanaflex) has been associated with hypotension, which could be a safety risk, especially if the patient is also taking an antihypertensive drug. Constipation, dry mouth, and fatigue are common adverse effects that do not pose a safety risk. Question 3 1 out of 1 points A nurse is instructing a patient in the administration of regular insulin by the subcutaneous route. Which of the following strategies would the nurse suggest if the goal is to promote absorption of the regular insulin? Response Feedback: To promote the absorption of regular insulin, one anatomic area should be selected for subcutaneous injections. Serial locations within that anatomic area are then chosen to rotate the exact injection site. Injection sites should not be rotated by using different anatomic areas each day, because this would substantially change the absorption of the insulin and the patient's blood glucose levels. Using one injection site regularly may lead to lipodystrophy. Regular insulin is administered about 30 to 60 minutes before eating a meal, not after. Question 4 1 out of 1 points A female patient with a diagnosis of type 1 diabetes mellitus has been experiencing increasing neuropathic pain in recent months, a symptom that has not responded appreciably to conventional analgesics. The patient's care provider has begun treatment with gabapentin (Neurontin). How is the addition of this drug
likely to influence the management of the patient's existing drug regimen?
You've reached the end of your free preview.
Want to read all 7 pages?